EUVIMEDEUVIMED entdecken
Crossref

Prionogenicity of vimentin surmised from the sequelog of anti-idiotypic antibodies toward the paratope of malignant-associated autologous anti-vimentin antibody, CLN-IgG (Pritumumab)

British Journal of Cancer Research · 2018

DOI: 10.31488/bjcr.1000104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Cancer Research, 2018.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2018). Prionogenicity of vimentin surmised from the sequelog of anti-idiotypic antibodies toward the paratope of malignant-associated autologous anti-vimentin antibody, CLN-IgG (Pritumumab). British Journal of Cancer Research. https://doi.org/10.31488/bjcr.1000104

Vancouver

Prionogenicity of vimentin surmised from the sequelog of anti-idiotypic antibodies toward the paratope of malignant-associated autologous anti-vimentin antibody, CLN-IgG (Pritumumab). British Journal of Cancer Research. 2018. doi:10.31488/bjcr.1000104

BibTeX
@article{euvimed2018,
  title = {Prionogenicity of vimentin surmised from the sequelog of anti-idiotypic antibodies toward the paratope of malignant-associated autologous anti-vimentin antibody, CLN-IgG (Pritumumab)},
  journal = {British Journal of Cancer Research},
  year = {2018},
  doi = {10.31488/bjcr.1000104}
}
Kostenlos starten →